Ukrainian Atherosclerosis Society
   UKRAINIAN ATHEROSCLEROSIS SOCIETY
  
  


   UA           EN         
Ukrainian Association of Cardiology
Home About UAS News Publications Events Videos Contact Us

News
  • Coronary artery calcium score may have a role in stratifying short-term risk in patients with familial hypercholesterolaemia...
  • Evolocumab reduces lipoprotein levels but not arterial wall inflammation...
  • High lipoprotein(a) concentra-tions and high risk of mortality...
  • EWTOPIA75: Ezetimibe prevents the development of the first cardiovascular events in the elderly...
  • Top 10 Take-Home Messages to Reduce Risk of Atherosclerotic Cardiovascular Disease Through Cholesterol Management ...
  • Updated AHA/ACC cholesterol guidelines focus on more personalized risk assessment...
  • 2018 US Cholesterol Guidelines: what has changed after 5 years?...
  • REDUCE-IT: Pure Fish Oil Lowers CVD Risk...
     

    Cooperation
      NSC The M.D.Strazhesko Institute of Cardiology NAMS of Ukraine
      European Atherosclerosis Society (EAS)
      International Atherosclerosis Society (IAS)
      Ukrainian Antihypertensive Society

     
     
    2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA Guideline on the Management of Blood Cholesterol
        

    Since 1980, the American College of Cardiology (ACC) and the American Heart Association (AHA) have been developing recommendations for improving approaches to the diagnosis, treatment and prevention of lipid metabolism disorders in patients with cardiovascular diseases based on evidence-based medicine. In the period since the publication of the previous version in 2013 and by 2017, the results of numerous new large multicenter studies, the conclusions of which have been embodied in this edition, were obtained.

    The recommendations are written in a modular format, in which each section contains a table, a brief overview, a reference text and flowcharts or additional tables. The recommendations for the diagnosis and treatment of hypercholesterolemia focus on medical practice in the United States, but this guide is relevant to physicians and patients around the world.

    Full text of recommendations in PDF format

    www.ahajournals.org/doi/10.1161/CIR.0000000000000625

     
     
    GUIDELINES FOR THERAPY OF STABLE IHD (CHD)
        

    In 2013, new European guidelines for the management of patients with stable ischemic heart disease (CHD) were published. The presented version of such recommendations is adapted to the Ukrainian cardiology practice. Compared to the European recommendations of 2006, a number of significant changes were made to the new document in the definition, diagnosis and treatment of the disease. So, for the purpose of determining nosology, instead of the previous "stable angina pectoris", the term "stable coronary artery disease" is used, which, of course, is more accurate from the point of view of the pathogenetic nature of the disease. It should be noted that according to the WHO nomenclature, this term is considered synonymous with "coronary heart disease (CHD)". In turn, IBS is a commonly used name of pathology in Ukraine, so the term is used in the text in the future.

    New recommendations include the following changes:

    • In the diagnostic algorithm of the CHD more attention is paid to determining the pre-test probability of the disease.
    • It is planned that the use of up-to-date information on the pre-test probability will reduce the frequency of unreasonable diagnosis of coronary artery disease, especially in women.
    • In the diagnosis of coronary artery disease, the role of visualization techniques, such as magnetic resonance imaging, computed tomography, angiography, is increasing.
    • More attention is paid to coronary vasospasm and microvascular disfunction, as a sufficiently common cause of angina (breast pain).
    • It is recommended that a clear distinction be made between diagnosing and assessing the prognosis as separate stages in the management of patients with suspected stable CHD.
    • More attention is paid to combating risk factors and thus to prevent serious coronary events.
    • Recommendations updated on the use of anti-anginal drugs.
    • Recommended for the introduction of new methods for assessing ischemia and coronary artery disease, as well as technical devices for myocardial revascularization.
    • Separately, the issue of the treatment strategy is discussed: revascularization against drug treatment, and the choice of revascularization method depending on the patient's needs.

    Full text of GUIDELINES in PDF format(only in Ukrainian)

     
     
    DIABETES, PREDIABETES AND CARDIOVASCULAR DISEASES
        

    This is the second edition of the GUIDELINES of the European Society of Cardiology (ESC) for the treatment of diabetes mellitus (DM), pre-diabetes and cardiovascular disease (CVD), which are intended to help clinicians and other health workers to make scientifically sound decisions. The ESC's guidelines for developing the main principles are presented below:

    Full text of GUIDELINES in PDF format (only in Ukrainian)

     
     
    DYSLIPIDEMIA: DIAGNOSIS, PREVENTION AND TREATMENT
        

    These GUIDELINES were prepared by the Ukrainian Atherosclerosis Society r on behalf of the Association of Cardiologists of Ukraine and are based on the Consensus on Evidence Based Medicine, developed by the 2016 Working Group of the European Society of Cardiology and the European Atherosclerosis Society . The recommendations take into account the mandatory criteria to be met:

    Full text of GUIDELINES in PDF format (only in Ukrainian)

     
     
     
    Announcements

    EAS Congress,2019/05/26-05/29




    ESC Congress,2019/08/31-09/04



    Feedback

    You can send your materials, wishes and letters to the address
     
     
    UAS in Social Networks

    Facebook   Twitter   LinkedIn
    Home |  About UAS |  News |  Publications |  Events |  Videos |  Contact us
    2018 UAS
    UAS site is supported by "Dr.Reddy's Labs" in Ukraine